Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia

Journal of Clinical Microbiology

Volumn 43, Issue 7, 2005, Pages 3066-3073

  Stevens, Servi J C ^a   Verkuijlen, Sandra A W M ^a   Hariwiyanto, Bambang ^b   Harijadi, ^b   Fachiroh, Jajah ^b   Paramita, Dewi K ^b   Tan, I Bing ^c   Haryana, Sophia M ^b   Middeldorp, Jaap M ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GADJAH MADA UNIVERSITY   (Indonesia)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MESSENGER RNA; SMALL NUCLEAR RIBONUCLEOPROTEIN; VIRUS DNA;

AMPLICON; ANTIBODY TITER; ARTICLE; BARF1 GENE; CANCER DIAGNOSIS; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INDONESIA; LYMPHOMA; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SOUTHEAST ASIA; VIRUS LOAD; VIRUS ONCOGENE;

ANTIBODIES, VIRAL; CARCINOMA; DNA, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INDONESIA; NASOPHARYNGEAL NEOPLASMS; RNA, MESSENGER; VIRAL LOAD;

HUMAN HERPESVIRUS 4;

EID: 22144449983     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.7.3066-3073.2005     Document Type: Article

References (69)

1. Bai, X., G. Hosler, B. B., Rogers, D. B. Dawson, and R. H. Scheuermann. 1997. Quantitative polymerase chain reaction for human herpesvirus diagnosis measurement of Epstein-Barr virus burden in posttransplant lymphoproliferative disorder. Clin. Chem. 43:1843-1849.
2. Bai, X., B. B. Rogers, P. C. Harkins, J. Sommerauer, R. Squires, K. Rotondo, A. Quan, D. B. Dawson, and R. H. Scheuermann. 2000. Predictive value of quantitative PCR-based viral burden analysis for eight human herpesviruses in pediatric solid organ transplant patients. J. Mol. Diagn. 2:191-201.
3. Boom, R., C. J. Sol, T. Schuurman, A. Van Breda, J. F. Weel, M. Beld, I. J. Ten Berge, P. M. Wertheim-Van Dillen, and M. D. De Jong. 2002. Human cytomegalovirus DNA in plasma serum specimens of renal transplant recipients is highly fragmented. J. Clin. Microbiol. 40:4105-4113.
4. Boom, R., C. J. A. Sol, M. M. M. Salimans, C. L. Jansen, P. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
5. Brink, A. A. T. P., M. B. H. J. Veryoort, J. M. Middeldorp, C. J. L. M. Meijer, and A. J. C. van den Brule. 1998. Nucleic acid sequence-based amplification, a new method for analysis of spliced unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR. J. Clin. Microbiol. 36:3164-3169.
6. Bruisten, S. M., P. Oudshoorn, P. van Swieten, B. Boeser-Nunnink, P. van Aarle, S. P. Tondreau, and H. T. Cuypers. 1997. Stability of HIV-1 RNA in blood during specimen handling storage prior to amplification by NASBA-QT. J. Virol. Methods 67:199-207.
7. Chan, A. T., Y. M. Lo, B. Zee, L. Y. Chan, B. B. Ma, S. F. Leung, F. Mo, M. Lai, S. Ho, D. P. Huang, and P. J. Johnson. 2002. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J. Natl. Cancer Inst. 94:1614-1619.
8. Chan, K. C., J. Zhang, A. T. Chan, K. I. Lei, S. F. Leung, L. Y. Chan, K. C. Chow, and Y. M. Lo. 2003. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma lymphoma patients. Cancer Res. 63:2028-2032.
9. Chan, K. H., Y. L. Gu, F. Ng, P. S. Ng, W. H. Seto, J. S. Sham, D. Chua, W. Wei, Y. L. Chen, W. Luk, Y. S. Zong, and M. H. Ng. 2003. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int. J. Cancer 105:706-709.
10. Chang, H. W., A. Chan, D. L. Kwong, W. I. Wei, J. S. Sham, and A. P. Yuen. 2003. Detection of hypermethylated RIZ1 gene in primary tumor, mouth, throat rinsing fluid, nasopharyngeal swab, peripheral blood of nasopharyngeal carcinoma patient. Clin. Cancer Res. 9:1033-1038.
11. Damen, M., P. Sillekens, M. Sjerps, R. Melsert, I. Frantzen, H. W. Reesink, P. N. Lelie, and H. T. Cuypers. 1998. Stability of hepatitis C virus RNA during specimen handling storage prior to NASBA amplification. J. Virol. Methods 72:175-184.
12. Decaussin, G., F. Sbih-Lammali, M. de Turenne-Tessier, A. Bouguermouh, and T. Ooka. 2000. Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies. Cancer Res. 60:5584-5588.
13. Deiman, B., P. van Aarle, and P. Sillekens. 2000. Characteristics and applications of nucleic acid sequence-based amplification (NASBA). Mol. Biotechnol. 20:163-167.
14. Dyson, P. J., and P. J. Farrell. 1985. Chromatin structure of Epstein-Barr virus. J. Gen. Virol. 66:1931-1940.
15. Fachiroh, J., T. Schouten, B. Hariwiyanto, D. K. Paramita, A. Harijadi, S. M. Haryana, M. H. Ng, and J. M. Middeldorp. 2004. Molecular diversity of Epstein-Barr virus IgG IgA antibody responses in nasopharyngeal carcinoma: a comparison of Chinese, Indonesian and European cases. J. Infect. Dis. 190:53-62.
16. Feng, P., E. C. Ren, D. Liu, S. H. Chan, and H. Hu. 2000. Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis. J. Gen. Virol. 81:2417-2423.
17. Ferlay, J., F. Bray, and P. Pisani (ed.). 2001. Globocan 2000: Cancer incidence, mortality prevalence worldwide. International Agency for Research on Cancer. Lyon, France.
18. Finke, J., M. Rowe, B. Kallin, I. Ernberg, A. Rosen, J. Dillner, and G. Klein. 1987. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. J. Virol. 61:3870-3878.
19. Greijer, A. E., C. A. Dekkers, and J. M. Middeldorp. 2000. Human cytomegalovirus virions differentially incorporate viral host cell RNA during the assembly process. J. Virol. 74:9078-9082.
20. Gulley, M. L. 2001. Molecular diagnosis of Epstein-Barr virus-related diseases. J. Mol. Diagn. 3:1-10.
21. Hayes, D. P., A. A. T. P. Brink, M. B. H. J. Vervoort, J. M. Middeldorp, C. J. L. M. Meijer, and A. J. C. van den Brule. 1999. Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV-associated diseases. Mol. Pathol. 52:97-103.
22. Henle, G., and W. Henle. 1976. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int. J. Cancer 17:1-7.
23. Hochberg, D., J. M. Middeldorp, M. Catalina, J. L. Sullivan, K. Luzuriaga, and D. A. Thorley-Lawson. 2004. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc. Natl. Acad. Sci. USA 101:239-244.
24. Hong, R. L., C. Y. Lin, L. L. Ting, J. Y. Ko, and M. M. Hsu. 2004. Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein-Barr virus DNA. Cancer 100:1429-1437.
25. Hsiao, J. R., Y. T. Jin, and S. T. Tsai. 2000. Detection of cell free Epstein-Barr virus DNA in sera from patients with nasopharyngeal carcinoma. Cancer 94:723-729.
26. Hu, L. F., F. Chen, X. Zheng, I. Ernberg, S. L. Cao, B. Christensson, G. Klein, and G. Winberg. 1993. Clonability tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogens 8:1575-1583.
27. International Agency for Research on Cancer. 1997. Epstein-Barr virus Kaposi's sarcoma herpesvirus/human herpesvirus 8. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 70. International Agency for Research on Cancer, Lyon, France.
28. Kondo, S., T. Horikawa, H. Takeshita, C. Kanegane, Y. Kasahara, T. S. Sheen, H. Sato, M. Furukawa, and T. Yoshizaki. 2004. Diagnostic value of serum EBV-DNA quantification antibody to viral capsid antigen in nasopharyngeal carcinoma patients. Cancer Sci. 95:508-513.
29. Kwok, S., and R. Higuchi. 1989. Avoiding false positives with PCR. Nature 339:237-238.
30. Leung, S. F., A. T. Chan, B. Zee, B. Ma, L. Y. Chan, P. J. Johnson, and Y. M. Lo. 2003. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type. Cancer 98:288-291.
31. Leung, S. F., Y. M. Lo, A. T. Chan, K. F. To, E. To, L. Y. Chan, B. Zee, D. P. Huang, and P. J. Johnson. 2003. Disparity of sensitivities in detection of radiation-naive postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA. Clin. Cancer Res. 9:3431-3434.
32. Lin, J. C., K. Y. Chen, W. Y. Wang, J. S. Jan, W. M. Liang, C. S. Tsai, and Y. H. Wei. 2001. Detection of Epstein-Barr virus DNA in the peripheral blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis survival. J. Clin. Oncol. 19:2607-2615.
33. Lin, J. C., W. Y. Wang, K. Y. Chen, Y. H. Wei, W. M. Liang, J. S. Jan, and R. S. Jiang. 2004. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N. Engl. J. Med. 350: 2461-2470.
34. Lo, Y. M., L. Y. Chan, A. T. Chan, S. F. Leung, K. W. Lo, J. Zhang, J. C. Lee, N. M. Hjelm, P. J. Johnson, and D. P. Huang. 1999. Quantitative temporal correlation between circulating cell-free Epstein-Barr virus DNA tumor recurrence in nasopharyngeal carcinoma. Cancer Res. 59:5452-5455.
35. Meij, P., M. B. H. J. Vervoort, C. J. L. M. Meijer, E. B. Bloemena, and J. M. Middeldorp. 2000. Production monitoring and purification of EBV encoded latent membrane protein 1 expressed secreted by recombinant baculovirus infected insect cells. J. Virol. Methods 90:193-204.
36. Meij, P., M. B. H. J. Vervoort, K. de Goojier, E. B. Bloemena, C. J. L. M. Meijer, and J. M. Middeldorp. 2000. Bioreactor-scale production and one-step purification of Epstein-Barr nuclear antigen 1 expressed in baculovirus-infected insect cells. Prot. Express. Purif. 20:324-333.
37. Middeldorp, J. M., A. A. T. P. Brink, A. J. C. van den Brule, and C. J. L. M. Meijer. 2003. Pathogenic role for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Clin. Rev. Oncol. Hematol. 45:1-36.
38. Mutirangura, A., W. Pornthanakasem, A. Theamboonlers, V. Sriuranpong, P. Lertsanguansinchi, S. Yenrudi, N. Voravud, P. Supiyaphun, and Y. Poovorawan. 1998. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin. Cancer Res. 4:665-669.
39. Nagata, S., H. Nagase, K. Kawane, N. Mukae, and H. Fukuyama. 2003. Degradation of chromosomal DNA during apoptosis. Cell Death Differentiation 10:108-116.
40. Niedobitek, G. 2000. Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Mol. Pathol. 53:248-254.
41. Pratesi, C., M. T. Bortolin, M. D'Andrea, E. Vaccher, L. Barzan, E. Bidoli, R. Tedeschi, S., Zanussi, and P. de Paoli. 2003. Quantitative plasma/serum EBV DNA load by LMP2a determination in an Italian cohort of NPC patients. J. Clin. Virol. 28:155-164.
42. Raab-Traub, N. 2002. Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 12:431-441.
43. Rowe, D. T., L. Qu, J. Reyes, N. Jabbour, E. Yunis, P. Putnam, S. Todo, and M. Green. 1997. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J. Clin. Microbiol. 35: 1612-1615.
44. Rowe, D. T., S. Webber, E. M. Schauer, J. Reyes, and M. Green. 2001. Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease. Transplant. Infect. Dis. 3:79-87.
45. Sall, A., S. Caserta, P. Jolicoeur, L. Franqueville, M. Turenne-Tessier, and T. Ooka. 2004. Mitogenic activity of Epstein-Barr virus-encoded BARF1 protein. Oncogene 23:4938-4949.
46. Scholle, F., K. M. Bendt, and N. Raab-Traub. 2000. Epstein-Barr virus LMP2a transforms epithelial cells, inhibits cell differentiation activates AKT. J. Virol. 74:10681-10689.
47. Shao, J. Y., Y. H. Li, H. Y. Gao, Q. L. Wu, N. J. Cui, I. Zhang, G. Cheng, L. F. Hu, I. Ernberg, and Y. X. Zeng. 2004. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer 100:1162-1170.
48. Shotelersuk, K., C. Khorprasert, S. Sakdikul, W. Pornthanakasem, N. Voravud, and A. Mutirangura. 2000. Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer. Clin. Cancer Res. 6:1046-1051.
49. Sobin, L. H., and C. Wittekind (ed.). 1997. UICC TNM classification of malignant tumors, 5th ed. Springer-Verlag, Berlin, Germany.
50. Soeripto. 1998. Epidemiology of nasopharyngeal carcinoma. Berita Kedokteran Masyarakat XIII:207-211.
51. Stevens, S. J. C., B. S. N. Blank, P. H. M. Sraits, P. L. Meenhorst, and J. M. Middeldorp. 2002. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with anti-retroviral therapy and quantitative EBV serology. AIDS 16:993-1001.
52. Stevens, S. J. C., I. Pronk, and J. M. Middeldorp. 2001. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen. J. Clin. Microbiol. 29:1211-1216.
53. Stevens, S. J. C., S. A. W. M. Verkuglen, and J. M. Middeldorp. 2004. Quantitative detection of Epstein-Barr virus DNA in clinical specimens by rapid real-time PCR targeting a highly conserved region of EBNA-1. Methods Mol. Biol. 291:15-25.
54. Stevens, S. J. C., S. A. W. M. Verkuylen, A. J. C. van den Brule, and J. M. Middeldorp. 2002. Comparison of quantitative competitive PCR with LightCycler-based PCR for monitoring of Epstein-Barr virus DNA load in clinical specimens. J. Clin. Microbiol. 40:3986-3992.
55. Stevens, S. J. C., E. A. M. Verschuuren, I. Pronk, W. van der Bij, M. Harmsen, T. H. The, C. J. L. M. Meijer, A. J. C. van den Brule, and J. M. Middeldorp. 2001. Frequent monitoring of EBV DNA load in unfractionated whole blood is essential for early detection of PTLD in high risk patients. Blood 97:1165-1171.
56. Stevens, S. J. C., E. A. M. Verschuuren, S. A. W. M. Verkuijlen, A. J. C. van den Brule, C. J. L. M. Meijer, and J. M. Middeldorp. 2002. Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease. Leuk. Lymphoma 43:831-840.
57. Stevens, S. J. C., M. B. H. J. Vervoort, A. J. C. van den Brule, P. L. Meenhorst, C. J. L. M. Meger, and J. M. Middeldorp. 1999. Monitoring of Epstein-Barr virus DNA load in peripheral blood by quantitative competitive polymerase chain reaction. J. Clin. Microbiol. 37:2852-2857.
58. Thorley-Lawson, D. A. 2001. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1:75-82.
59. To, E. W., K. C. Chan, S. F. Leung, L. Y. Chan, K. F. To, A. T. Chan, P. J. Johnson, and Y. M. Lo. 2003. Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. Clin. Cancer Res. 9:3254-3259.
60. Tong, J. H., R. K. Tsang, K. W. Lo, J. K. Woo, J. Kwong, M. W. Chan, A. R. Chang, and C. A. van Hasselt. 2002. Quantitative Epstein-Barr virus DNA analysis detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. Clin. Cancer Res. 8:2612-2619.
61. Trumper, P., M. A. Epstein, B. C. Giovanella, and S. Finerty. 1977. Isolation of infectious EB virus from the epithelial tumour cells of nasopharyngeal carcinoma. Int. J. Cancer 20:655-662.
62. Wadowsky, R. M., S. Laus, M. Green, S. A. Webber, and D. Rowe. 2003. Measurement of Epstein-Barr virus DNA loads in whole blood plasma by TaqMan PCR in peripheral blood lymphocytes by competitive PCR. J. Clin. Microbiol. 41:5245-5249.
63. Wagner, H. J., W. Jabs, W., F. Smets, M. Wessel, L. Fischer, G. Offner, H. Kirchner, and P. Bucsky. 2000. Real-time polymerase chain reaction (RQ-PCR) for the monitoring of Epstein-Barr virus (EBV) load in peripheral blood mononuclear cells. Klin. Padiatr. 212:206-210.
64. Wei, M. X., M. de Turenne-Tessier, G. Decaussin, G. Benet, and T. Ooka. 1997. Establishment of a monkey kidney epithelial cell line with the BARF1 open reading frame from Epstein-Barr virus. Oncogene 14:3073-3081.
65. Wei, M. X., and T. Ooka. 1989. A transforming function of the BARF1 gene encoded by Epstein-Barr virus. EMBO J. 8:2897-2903.
66. Wong, T. S., H. W. Chang, K. C. Tang, W. I. Wei, D. L. Kwong, J. S. Sham, A. P. Yuen, and Y. L. Kwong. 2002. High frequency of promoter hypermethylation of the death-associated protein-kinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients. Clin. Cancer Res. 8:433-437.
67. Yang, J., Q. Tao, I. W. Flinn, P. G. Murray, L. E. Post, H. Ma, S. Piantadosi, M. A. Caligiuri, and R. F. Ambinder. 2000. Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. Blood 96:4055-4063.
68. Zhang, J. X., H. L. Chen, Y. S. Zong, K. H. Chan, J. Nicholls, J. M. Middeldorp, J. S. Sham, B. E. Griffin, and M. H. Ng. 1998. Epstein-Barr virus expression within keratinizing nasopharyngeal carcinoma. J. Med. Virol. 55:227-233.
69. zur Hausen, A., A. A. T. P. Brink, M. E. Craanen, J. M. Middeldorp, C. J. L. M. Meijer, and A. J. C. van den Brule. 2000. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res. 60:2745-2748.